|
WAPAL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63657976059994E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.16080478562708E-11 |
| Normal-vs-Stage2 |
5.68410000179043E-08 |
| Normal-vs-Stage3 |
2.27150520615282E-11 |
| Normal-vs-Stage4 |
2.04836148043341E-12 |
| Stage1-vs-Stage2 |
6.658400E-01 |
| Stage1-vs-Stage3 |
3.852800E-01 |
| Stage1-vs-Stage4 |
4.079100E-03 |
| Stage2-vs-Stage3 |
8.474200E-01 |
| Stage2-vs-Stage4 |
9.661500E-02 |
| Stage3-vs-Stage4 |
9.076100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-14 |
| Normal-vs-AfricanAmerican |
3.794800E-04 |
| Normal-vs-Asian |
4.43220016244084E-10 |
| Caucasian-vs-AfricanAmerican |
2.316600E-01 |
| Caucasian-vs-Asian |
5.276600E-01 |
| AfricanAmerican-vs-Asian |
1.219350E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.5660810122381E-12 |
| Normal-vs-Female |
1.77391434874608E-12 |
| Male-vs-Female |
7.800800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.41169964607002E-10 |
| Normal-vs-Age(41-60Yrs) |
1.28008714739281E-13 |
| Normal-vs-Age(61-80Yrs) |
6.81089962206727E-10 |
| Normal-vs-Age(81-100Yrs) |
6.597800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.841350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.546400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.600200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.334800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.420800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.996400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.470780E-01 |
| Classical-VS-Follicular |
6.239800E-01 |
| Classical-VS-Other |
3.383800E-01 |
| Classical-VS-Normal |
3.83004739035187E-12 |
| Tall-VS-Follicular |
3.540800E-01 |
| Tall-VS-Other |
8.381000E-01 |
| Tall-VS-Normal |
6.79380000034868E-08 |
| Follicular-VS-Other |
4.982400E-01 |
| Follicular-VS-Normal |
1.67849999455072E-08 |
| Other-VS-Normal |
1.341170E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.93955962402015E-13 |
| Normal-vs-N1 |
1.1296519275561E-12 |
| N0-vs-N1 |
4.680500E-02 |
|
|
